Pharmaceutical Stocks To Add to Your Watchlist – February 07th

Eli Lilly and Company, Honeywell International, Merck & Co., Inc., Doximity, and Neurocrine Biosciences are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares in companies that develop, produce, and sell medications and drugs. These stocks can be impacted by factors like drug approvals, clinical trial results, and overall market demand for healthcare products. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded up $12.19 during trading hours on Friday, hitting $882.56. The stock had a trading volume of 2,609,180 shares, compared to its average volume of 3,934,405. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.27 and a quick ratio of 0.97. The stock has a market capitalization of $837.83 billion, a price-to-earnings ratio of 95.41, a P/E/G ratio of 1.72 and a beta of 0.42. The company’s fifty day moving average is $788.21 and its two-hundred day moving average is $843.47. Eli Lilly and Company has a 52 week low of $711.40 and a 52 week high of $972.53.

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

Shares of HON stock traded down $2.62 on Friday, reaching $207.20. 3,097,053 shares of the stock were exchanged, compared to its average volume of 3,860,062. Honeywell International has a one year low of $189.75 and a one year high of $242.77. The stock has a 50 day moving average price of $225.07 and a 200 day moving average price of $215.19. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.44 and a quick ratio of 1.12. The stock has a market cap of $134.73 billion, a PE ratio of 23.97, a P/E/G ratio of 2.57 and a beta of 1.05.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Merck & Co., Inc. stock traded down $0.03 during mid-day trading on Friday, hitting $88.02. 7,159,553 shares of the company’s stock were exchanged, compared to its average volume of 13,274,712. The company’s 50 day simple moving average is $99.01 and its 200-day simple moving average is $106.87. Merck & Co., Inc. has a fifty-two week low of $87.20 and a fifty-two week high of $134.63. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $222.67 billion, a P/E ratio of 18.45, a PEG ratio of 1.20 and a beta of 0.38.

Doximity (DOCS)

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

DOCS stock traded up $20.96 during trading hours on Friday, reaching $79.22. 7,582,438 shares of the stock were exchanged, compared to its average volume of 1,794,991. The company has a market cap of $14.79 billion, a price-to-earnings ratio of 90.32, a PEG ratio of 4.68 and a beta of 1.39. The firm’s 50-day moving average is $55.09 and its 200-day moving average is $45.31. Doximity has a 12 month low of $22.96 and a 12 month high of $80.71.

Neurocrine Biosciences (NBIX)

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Neurocrine Biosciences stock traded down $26.44 during midday trading on Friday, reaching $124.07. The stock had a trading volume of 4,338,864 shares, compared to its average volume of 1,111,115. The stock has a market capitalization of $12.56 billion, a P/E ratio of 33.27 and a beta of 0.33. The firm’s fifty day simple moving average is $138.89 and its 200-day simple moving average is $131.77. Neurocrine Biosciences has a 1-year low of $110.95 and a 1-year high of $157.98.